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Abstract Thiopurine S-methyltransferase (TPMT) is a cyto-
solic enzyme that catalyzes S-methylation of aromatic and
heterocyclic sulfhydryl compounds, including anticancer and
immunosuppressive thiopurines. Here we report the isolation and
functional characterization of the murine TPMT cDNA. The
screening of expressed sequence tags database led to isolation of
a murine cDNA clone containing an uninterrupted ORF encoding
the protein with an amino acid sequence that is 82% similar and
78% identical to the human TPMT. The expression product of
the murine cDNA in rabbit reticulocyte and wheat germ lysate
coupled transcription-translation systems showed TPMT enzy-
matic activity. We conclude that the isolated cDNA clone
represents the murine TPMT cDNA.
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1. Introduction
Thiopurine S-methyltransferase (TPMT, EC 2.1.1.67) is a
cytoplasmic transmethylase originally found in kidney and
liver of rodents [1]. Using S-adenosyl-methionine as a methyl
donor, this enzyme catalyzes methylation of sulfur atoms in
aromatic and heterocyclic compounds. TPMT was shown to
be present in erythrocytes, kidney and liver, and TPMT
mRNA was detected in most human tissues, e.g. heart, blood
cells, placenta, pancreas, intestine [2,3]. Human TPMT has a
molecular mass of 28 kDa and comprises 245 amino acids.
Interest in this enzyme is enhanced by the crucial role TPMT
plays in metabolism of the important antileukemic and immu-
nosuppressive drugs mercaptopurine, thioguanine and aza-
thioprine [4]. TPMT activity shows co-dominant genetic poly-
morphism, with about 10% of the population inheriting a
lower activity of this enzyme. Recent studies have elucidated
the molecular basis for inherited TPMT de¢ciency [2,5^7] and
provided genotyping assays to detect individuals with im-
paired activity of TPMT [8]. Isolation of the human TPMT
chromosomal gene [7,9] and characterization of its promoter
region have made it possible to characterize the regulation of
TPMT (Fessing et al., unpublished). Despite signi¢cant prog-
ress in molecular genetics of TPMT, many biochemical ques-
tions remain unanswered including its endogenous substrate
and biological functions. Comparison of the human TPMT
amino acid sequence revealed little homology with other
methyltransferases, and no SAM-binding motifs were found
in its primary structure [10^12].
To date, the amino acid sequence deduced from the cDNA
was determined only for human TPMT [2,11]. Here we report
the ¢rst isolation and characterization of the murine TPMT
cDNA. Isolation of the murine TPMT provides an important
new tool for gaining further insight into the biochemical func-
tions and regulation of this enzyme.
2. Materials and methods
A computer search for homologous sequences was performed at the
National Center for Biotechnology Information, using the BLAST
network service. The University of Wisconsin Genetic Computer
Group software package was used to analyze sequence information
(Genetic Computer Group, 1991).
cDNA clones MGI:314202 (GenBank accession number
AA109870) isolated from C57/BL6 cDNA library and MGI:610617
(GenBank accession number AA637718) isolated from the C2C12 cell
line cDNA library were obtained from Genome Systems (St. Louis,
MO) and propagated according to the manufacturer’s instructions.
Plasmid DNA was isolated using the Qiagen Plasmid Midi Kit (Va-
lencia, CA). cDNA inserts were bidirectionally sequenced with an
Applied Biosystems DNA sequencer Model 373A and the ABI
PRISM dye Terminator Cycle Core Sequencing Kit, with AmpliTaq
DNA Polymerase, FS (Perkin Elmer, Foster City, CA), in the Center
for Biotechnology at SJCRH.
Preparation of plasmids with human TPMT*1 and TPMT*3A
cDNA and transcription-translation experiments in the rabbit reticu-
locyte lysate system (RRL) and wheat germ extract system (WGL)
(Promega, Madison, WI) were performed essentially as described ear-
lier [13].
Enzymatic activity of translation products was determined after
incubation of 1 Wg of the plasmid with the corresponding cDNA
insert, and 25 Wl of RRL or WGL in the 50 Wl reaction mixture,
for 1.5 h at 30‡C. Immediately thereafter, 200 Wg of 6MP in 10 Wl
of DMSO and 5 Wl of [14C-CH3]S-adenosyl-L-methionine (59 mCi/
mmol, NEN Life Science Products, Boston, MA) were added, and
the reaction mixture was incubated for another 1.5 h to determine
TPMT-catalyzed 6MP S-methylation activity. The methylation prod-
ucts were extracted with 1 ml of chloroform, dried in vacuum and
applied on a TLC plate coated with Kieselgel 60 F254 (Merck, Ger-
many). Analysis of methylation products was carried out by TLC in
nPrOH-nBuOH-formic acid-water (60:20:19:1). Chromatograms
were treated with En3hance surface autoradiography enhancer (Du-
Pont, Boston, MA). Radioautography was carried out at 70‡C over-
night.
3. Results and discussion
3.1. Isolation of the murine TPMT cDNA
Using the sequence of the open reading frame (ORF) of the
human TPMT as a query, we screened the GenBank dbEST
(expressed sequence tags) database [14] for homologous se-
quences. Two sequences (GenBank accession numbers
AA109870 and AA637718) derived from the murine cDNA
libraries were identi¢ed with 70^80% homology to the human
TPMT ORF. When translated into polypeptide sequences, 5P-
terminal sequences of both clones present in the GenBank
revealed 80% homology to the N-terminal fragment of the
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human TPMT. Therefore, we further characterized these
clones by bidirectional sequencing.
The nucleotide sequence of clone AA637718 contained a
cDNA insert of 1068 bp with a potential ORF of 723 bp in
length (the full sequence of the insert in clone AA637718 has
been submitted to GenBank with accession number
AF046887). This uninterrupted stretch of cDNA starts with
an ATG codon and ends with a TAA codon. The 3P-end
fragment of this cDNA contains a sequence identical to the
polyadenylation signal ATTAAA, about 17 bp upstream from
the end of the cDNA [15]. An uninterrupted ORF encoded a
240 amino acid polypeptide. The nucleotide sequence has 82%
similarity to the human TPMT sequence and is more than
99% similar to the sequence of clone AA109870. The amino
acid sequence of the corresponding polypeptide translated
from cDNA AA637718 is 82% similar and 78% identical to
that of the human TPMT (Fig. 1). Clone AA109870 derived
from the C57/BL6 murine cDNA library contained an addi-
tional insert resulting in a frameshift that produced prelimi-
nary termination of the ORF, and was therefore not charac-
terized further. Presence of this inactivating mutation
indirectly supports the observation of decreased TPMT activ-
ity in the C57/BL6 strain [16], which was the source of RNA
for this cDNA library. Therefore, we hypothesize that the
AA109870 cDNA is from the inactive allele responsible for
low TPMT activity in the C57/BL6 mouse. About 70% sim-
ilarity was found between human and murine TPMT mRNA
sequences in the 5P-untranslated regions (UTR), with no sig-
ni¢cant homology in the 3P-UTR of mRNA.
Amino acid sequences within the ORF of clone AA637718
and human TPMT showed striking similarity in several re-
gions crucial for activity of human TPMT: amino acid resi-
dues at positions where inactivating mutations have been
found in the human TPMT are located in the most conserva-
tive regions of the protein, with corresponding nucleotides
identical in both sequences (see Fig. 1A) [6,8]. All but one
nucleotide corresponding to the exon-intron boundaries in
the human TPMT mRNA are conserved in the murine se-
quence [7,9]. The sequence of the C-terminal undecapeptide
of the mouse protein (LFEKLYLLTEK) is the same as in the
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Fig. 1. A: Comparison of the amino acid sequences of the human TPMT (upper line) and the translation product of AA637718 cDNA (bot-
tom line). Arrows indicate positions of inactivating mutations found in human TPMT (numbered according to [6,8]). B: Chou-Fasman predic-
tion of the secondary structures of human (left) and murine (right) TPMT proteins.
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human TPMT (Fig. 1A). When the secondary structure of the
human TPMT and the putative murine TPMT polypeptide
chain, as predicted by Chou-Fasman modelling [17], were
compared, they showed high similarity in both the number
and relative location of K-helices, L-sheets and turns (see
Fig. 1B).
3.2. Functional characterization of the murine TPMT cDNA
To verify that the isolated cDNA clone encodes a function-
al TPMT protein, we expressed this cDNA in RRL and
WGL, and documented TPMT activity in the reaction mix-
ture. We found signi¢cant TPMT enzymatic activity in the
reaction mixture after transcription-translation of the murine
cDNA: incubation of 6-mercaptopurine with radioactive
SAM in the presence of transcription-translation products of
cDNA AA637718 resulted in the formation of 14C-CH3-meth-
ylated mercaptopurine. TPMT activity was substantially high-
er than the endogenous TPMT activity in the RRL and WGL,
after expression of the cDNA encoding the inactive human
TPMT*3A allele (Fig. 2, lane 1 versus lane 3). Human wild
type cDNA was used as a positive control, and the product of
its transcription-translation revealed substantially higher ac-
tivity when compared to that of murine TPMT cDNA. Meth-
ylation of mercaptopurine was notably lower in WGL com-
parative to RRL, presumably due to lack of endogenous
TPMT activity in the former. The di¡erence in TPMT activity
for the murine and human translation products could prob-
ably be explained by relatively lower activity of the murine
protein, decreased e⁄ciency of transcription of mouse versus
human cDNAs (T7 versus SP6 RNA polymerases) and/or
decreased e⁄ciency of translation of the resulting murine
mRNA. The latter seems quite plausible, because the murine
mRNA has an approximately 100 nucleotides longer 5P-UTR
compared to the human TPMT mRNA. Further experiments
can now be undertaken to determine the relative activities of
the human and murine TPMT enzymes.
This study demonstrated that the murine cDNA AA637718
encodes a protein with high structural similarity to the human
TPMT protein sequence. When expressed, the protein en-
coded by this murine cDNA has thiopurine S-methyltransfer-
ase enzymatic activity, thus indicating that we have isolated
the functional murine TPMT cDNA. Isolation of the murine
cDNA permits future studies to compare the TPMT proteins
from mice and humans and thereby elucidate their functional
elements and mechanism(s) of enzymatic activity. This cDNA
also provides an important tool for cloning the murine TPMT
gene, which will facilitate future studies of the molecular biol-
ogy and physiological functions of TPMT.
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Fig. 2. Enzymatic activity of the translation product of AA637718
cDNA (lane 1), human TPMT*1 (lane 2), and mutant human
TPMT*3A cDNA (lane 3). After incubation of the recombinant
plasmids with RRL transcription-translation system, 6-mercaptopur-
ine and [14C-CH3]S-adenosyl-L-methionine were added to the reac-
tion mixture as indicated in Section 2. Arrow indicates the position
of authentic methylmercaptopurine.
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